Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Martin Broadstock, Clive Ballard & Anne Corbett. (2014) Latest treatment options for Alzheimer’s disease, Parkinson’s disease dementia and dementia with Lewy bodies. Expert Opinion on Pharmacotherapy 15:13, pages 1797-1810.
Read now
Read now
Articles from other publishers (21)
Rammohan Shukla, Nicholas D. Henkel, Khaled Alganem, Abdul-rizaq Hamoud, James Reigle, Rawan S. Alnafisah, Hunter M. Eby, Ali S. Imami, Justin F Creeden, Scott A. Miruzzi, Jaroslaw Meller & Robert E. Mccullumsmith. (2020) Signature-based approaches for informed drug repurposing: targeting CNS disorders. Neuropsychopharmacology 46:1, pages 116-130.
Crossref
Crossref
Enis Hidisoglu, Deniz Kantar‐Gok, Hakan Er, Alev Duygu Acun & Piraye Yargicoglu. (2018) Alterations in spontaneous delta and gamma activity might provide clues to detect changes induced by amyloid‐β administration. European Journal of Neuroscience 47:8, pages 1013-1023.
Crossref
Crossref
Feng Liu, Bangjian Dong, Xueyuan Yang, Yuling Yang, Jie Zhang, Da-Qing Jin, Yasushi Ohizumi, Dongho Lee, Jing Xu & Yuanqiang Guo. (2018) NO inhibitors function as potential anti-neuroinflammatory agents for AD from the flowers of Inula japonica. Bioorganic Chemistry 77, pages 168-175.
Crossref
Crossref
Chun Chen, Zhihao Wang, Zhentao Zhang, Xia Liu, Seong Su Kang, Ying ZhangKeqiang Ye. (2018) The prodrug of 7,8-dihydroxyflavone development and therapeutic efficacy for treating Alzheimer’s disease. Proceedings of the National Academy of Sciences 115:3, pages 578-583.
Crossref
Crossref
John Noel M. Viaña, James C. Vickers, Mark J. Cook & Frederic Gilbert. (2017) Currents of memory: recent progress, translational challenges, and ethical considerations in fornix deep brain stimulation trials for Alzheimer's disease. Neurobiology of Aging 56, pages 202-210.
Crossref
Crossref
Shmma Quraishe, Megan Sealey, Louise Cranfield & Amritpal Mudher. (2016) Microtubule stabilising peptides rescue tau phenotypes in-vivo. Scientific Reports 6:1.
Crossref
Crossref
Francesca Pistollato, Elan L. Ohayon, Ann Lam, Gillian R. Langley, Thomas J. Novak, David Pamies, George Perry, Eugenia Trushina, Robin S.B. Williams, Alex E. Roher, Thomas Hartung, Stevan Harnad, Neal Barnard, Martha Clare Morris, Mei-Chun Lai, Ryan Merkley & P. Charukeshi Chandrasekera. (2016) Alzheimer disease research in the 21st century: past and current failures, new perspectives and funding priorities. Oncotarget 7:26, pages 38999-39016.
Crossref
Crossref
Christophe Genicot & Laurent Provins. 2016. Lead Generation. Lead Generation
513
546
.
N Voyle, M Kim, P Proitsi, N J Ashton, A L Baird, C Bazenet, A Hye, S Westwood, R Chung, M Ward, G D Rabinovici, S Lovestone, G Breen, C Legido-Quigley, R J B Dobson & S J Kiddle. (2016) Blood metabolite markers of neocortical amyloid-β burden: discovery and enrichment using candidate proteins. Translational Psychiatry 6:1, pages e719-e719.
Crossref
Crossref
. 2016. Controlled Release Systems. Controlled Release Systems
441
464
.
Nicola Voyle, Aoife Keohane, Stephen Newhouse, Katie Lunnon, Caroline Johnston, Hilkka Soininen, Iwona Kloszewska, Patrizia Mecocci, Magda Tsolaki, Bruno Vellas, Simon Lovestone, Angela Hodges, Steven Kiddle & Richard JB. Dobson. (2015) A Pathway Based Classification Method for Analyzing Gene Expression for Alzheimer’s Disease Diagnosis. Journal of Alzheimer's Disease 49:3, pages 659-669.
Crossref
Crossref
Nicola Voyle, David Baker, Samantha C. Burnham, Antonia Covin, Zhanpan Zhang, Dipen P. Sangurdekar, Cristina A. Tan Hehir, Chantal Bazenet, Simon Lovestone, Steven Kiddle & Richard J.B. Dobson. (2015) Blood Protein Markers of Neocortical Amyloid-β Burden: A Candidate Study Using SOMAscan Technology. Journal of Alzheimer's Disease 46:4, pages 947-961.
Crossref
Crossref
Timothy A Couttas, Nupur Kain, Benjamin Daniels, Xin Ying Lim, Claire Shepherd, Jillian Kril, Russell Pickford, Hongyun Li, Brett Garner & Anthony S Don. (2014) Loss of the neuroprotective factor Sphingosine 1-phosphate early in Alzheimer’s disease pathogenesis. Acta Neuropathologica Communications 2:1.
Crossref
Crossref
Maria Antònia Busquets, Raimon Sabaté & Joan Estelrich. (2014) Potential applications of magnetic particles to detect and treat Alzheimer's disease. Nanoscale Research Letters 9:1.
Crossref
Crossref
Qingzhang Zhu, Jianchun Chen, Xi Wu, Xiaoping Jin & Bing Ruan. (2014) Repurposing of Kinase Inhibitors to Target c-Abl as Potential Therapeutics for Alzheimer?s Disease. Journal of Pharmaceutical Innovation 9:4, pages 331-340.
Crossref
Crossref
Shien Guo, Denis Getsios, Nikhil Revankar, Peng Xu, Gwilym Thompson, Joel Bobula, Loretto Lacey & Maren Gaudig. (2014) Evaluating Disease-Modifying Agents: A Simulation Framework for Alzheimer’s Disease. PharmacoEconomics 32:11, pages 1129-1139.
Crossref
Crossref
Debomoy K. Lahiri, Bryan Maloney, Justin M. Long & Nigel H. Greig. (2014) Lessons from a BACE1 inhibitor trial: Off‐site but not off base. Alzheimer's & Dementia 10:5S.
Crossref
Crossref
Minhua Zhang, Guangrui Luo, Yanjiao Zhou, Shaohui Wang & Zhong Zhong. (2014) Phenotypic Screens Targeting Neurodegenerative Diseases. SLAS Discovery 19:1, pages 1-16.
Crossref
Crossref
Clara Ibáñez, Carolina Simó, Dinesh K. Barupal, Oliver Fiehn, Miia Kivipelto, Angel Cedazo-Mínguez & Alejandro Cifuentes. (2013) A new metabolomic workflow for early detection of Alzheimer's disease. Journal of Chromatography A 1302, pages 65-71.
Crossref
Crossref
Anna M. Lilja, Yu Luo, Qian-sheng Yu, Jennie R?jdner, Yazhou Li, Ann M. Marini, Amelia Marutle, Agneta Nordberg & Nigel H. Greig. (2013) Neurotrophic and Neuroprotective Actions of (?)- and (+)-Phenserine, Candidate Drugs for Alzheimer?s Disease. PLoS ONE 8:1, pages e54887.
Crossref
Crossref
Sandra L. Friedman, David T. Helm & Ashley C. Woodman. (2012) Unique and Universal Barriers: Hospice Care for Aging Adults with Intellectual Disability. American Journal on Intellectual and Developmental Disabilities 117:6, pages 509-532.
Crossref
Crossref